tiprankstipranks
Trending News
More News >
Invivyd (IVVD)
NASDAQ:IVVD
US Market
Advertisement

Invivyd (IVVD) Earnings Dates, Call Summary & Reports

Compare
620 Followers

Earnings Data

Report Date
Mar 26, 2026
Before Open (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
-0.09
Last Year’s EPS
-0.15
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 06, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call highlighted significant positive developments such as FDA feedback for VYD2311, a successful capital raise, and robust revenue growth. However, challenges related to the lack of modern data on COVID vaccines and logistical coordination with FDA centers were noted.
Company Guidance
During the Q3 2025 earnings call, Invivyd provided guidance on several key metrics and strategic initiatives. The company highlighted its successful capital raise of approximately $87 million in the third quarter to support its pivotal clinical programs and commercial expansion. Invivyd plans to initiate its pivotal program for the antibody VYD2311 by year-end, with top-line data expected by mid-2026. The company aims to address COVID-19 prevention through the LIBERTY study, comparing VYD2311 to mRNA vaccines, focusing on safety and tolerability. Invivyd also reported increased revenues, up 11% quarter-on-quarter and 41% year-over-year, reflecting their strategic market efforts. The company emphasized its robust financial position, which supports anticipated pivotal data of VYD2311 and continued operational discipline. The call concluded with Invivyd expressing confidence in its innovative approach to COVID-19 prevention, potentially offering a superior option to existing vaccines.
FDA Feedback and Capital Raise
Invivyd received feedback from the U.S. FDA to develop the vaccine alternative antibody, VYD2311, and successfully raised approximately $87 million in capital to fund intended studies and expand the commercial organization.
Revenue Growth
Invivyd reported a revenue increase of 11% quarter-on-quarter and 41% year-over-year, reflecting efforts in driving market awareness.
Expansion in GPO Sites
The company has over 15,000 contracted GPO sites and more than 1,200 sites offering infusion, with 76% of accounts reordering.
Broad Commercial Opportunity
The company plans to provide a widely available option to prevent COVID for most Americans, with a near-term commercial opportunity, as last year's U.S. COVID vaccine sales totaled $3.8 billion.

Invivyd (IVVD) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

IVVD Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 26, 2026
2025 (Q4)
-0.09 / -
-0.15
Nov 06, 2025
2025 (Q3)
-0.08 / -0.06
-0.5188.24% (+0.45)
Aug 14, 2025
2025 (Q2)
>-0.01 / -0.12
-0.470.00% (+0.28)
May 15, 2025
2025 (Q1)
-0.03 / -0.14
-0.3863.16% (+0.24)
Mar 20, 2025
2024 (Q4)
-0.20 / -0.15
-0.6777.61% (+0.52)
Nov 14, 2024
2024 (Q3)
-0.34 / -0.51
-0.36-41.67% (-0.15)
Aug 14, 2024
2024 (Q2)
-0.37 / -0.40
-0.4613.04% (+0.06)
May 09, 2024
2024 (Q1)
-0.47 / -0.38
-0.32-18.75% (-0.06)
Mar 28, 2024
2023 (Q4)
-0.43 / -0.67
-0.41-63.41% (-0.26)
Nov 09, 2023
2023 (Q3)
-0.51 / -0.36
-0.4214.29% (+0.06)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

IVVD Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 06, 2025
$1.52$1.54+1.32%
Aug 14, 2025
$0.80$0.71-11.25%
May 15, 2025
$0.84$0.70-16.67%
Mar 20, 2025
$0.72$0.74+2.78%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Invivyd (IVVD) report earnings?
Invivyd (IVVD) is schdueled to report earning on Mar 26, 2026, Before Open (Confirmed).
    What is Invivyd (IVVD) earnings time?
    Invivyd (IVVD) earnings time is at Mar 26, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is IVVD EPS forecast?
          IVVD EPS forecast for the fiscal quarter 2025 (Q4) is -0.09.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis